Daniel Peterson: Difference between revisions
Notjusttired (talk | contribs) m (Undo revision 109895 by Notjusttired (talk)) |
Notjusttired (talk | contribs) m (Text replacement - " \|" to " |") |
||
Line 89: | Line 89: | ||
| last4 = Ruscetti | first4 = Francis W. | authorlink4 = | | last4 = Ruscetti | first4 = Francis W. | authorlink4 = | ||
| last5 = Lo | first5 = Shyh-Ching | authorlink5 = | | last5 = Lo | first5 = Shyh-Ching | authorlink5 = | ||
| last6 = Klimas | first6 = Nancy | | last6 = Klimas | first6 = Nancy | authorlink6 = Nancy Klimas | ||
| last7 = Komaroff | first7 = Anthony L. | authorlink7 = Anthony Komaroff | | last7 = Komaroff | first7 = Anthony L. | authorlink7 = Anthony Komaroff | ||
| last8 = Montoya | first8 = Jose G. | authorlink8 = Jose Montoya | | last8 = Montoya | first8 = Jose G. | authorlink8 = Jose Montoya | ||
| last9 = Bateman | first9 = Lucinda | authorlink9 = Lucinda Bateman | | last9 = Bateman | first9 = Lucinda | authorlink9 = Lucinda Bateman | ||
| last10 = Levine | first10 = Susan | | last10 = Levine | first10 = Susan | authorlink10 = Susan Levine | ||
| last11 = Peterson | first11 = Daniel | authorlink11 = Daniel Peterson | | last11 = Peterson | first11 = Daniel | authorlink11 = Daniel Peterson | ||
| last12 = Levin | first12 = Bruce | | last12 = Levin | first12 = Bruce | authorlink12 = Bruce Levin | ||
| last13 = Hanson | first13 = Maureen R. | authorlink13 = Maureen Hanson | | last13 = Hanson | first13 = Maureen R. | authorlink13 = Maureen Hanson | ||
| last14 = Genfi | first14 = Afia | | last14 = Genfi | first14 = Afia | authorlink14 = | ||
| last15 = Bhat | first15 = Meera | | last15 = Bhat | first15 = Meera | authorlink15 = | ||
| last16 = Zheng | first16 = HaoQiang | authorlink16 = | | last16 = Zheng | first16 = HaoQiang | authorlink16 = | ||
| last17 = Wang | first17 = Richard | authorlink17 = | | last17 = Wang | first17 = Richard | authorlink17 = | ||
Line 105: | Line 105: | ||
| last20 = Lee | first20 = Li Ling | authorlink20 = | | last20 = Lee | first20 = Li Ling | authorlink20 = | ||
| last21 = Sameroff | first21 = Stephen | authorlink21 = | | last21 = Sameroff | first21 = Stephen | authorlink21 = | ||
| last22 = Heneine | first22 = Walid | | last22 = Heneine | first22 = Walid | authorlink22 = | ||
| last23 = Coffin | first23 = John | | last23 = Coffin | first23 = John | authorlink23 = | ||
| last24 = Hornig | first24 = Mady | | last24 = Hornig | first24 = Mady | authorlink24 = Mady Hornig | ||
| last25 = Lipkin | first25 = W. Ian | authorlink25 = Ian Lipkin | | last25 = Lipkin | first25 = W. Ian | authorlink25 = Ian Lipkin | ||
| title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | | title = A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus | ||
Line 165: | Line 165: | ||
| last5 = Schultz | first5 = AF | authorlink5 = | | last5 = Schultz | first5 = AF | authorlink5 = | ||
| last6 = Eddy | first6 = ML | authorlink6 = | | last6 = Eddy | first6 = ML | authorlink6 = | ||
| last7 = Che | | last7 = Che | first7 = X | authorlink7 = | ||
| last8 = Lipkin | first8 = WI | authorlink8 = Ian Lipkin | | last8 = Lipkin | first8 = WI | authorlink8 = Ian Lipkin | ||
| title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | | title = Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. | ||
Line 177: | Line 177: | ||
| last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | | last2 = Gottschalk | first2 = G | authorlink2 = Gunnar Gottschalk | ||
| last3 = Eddy | first3 = ML | authorlink3 = | | last3 = Eddy | first3 = ML | authorlink3 = | ||
| last4 = Che | | last4 = Che | first4 = X | authorlink4 = | ||
| last5 = Ukaigwe | first5 = JE | authorlink5 = | | last5 = Ukaigwe | first5 = JE | authorlink5 = | ||
| last6 = Peterson | first6 = DL | authorlink6 = Daniel Peterson | | last6 = Peterson | first6 = DL | authorlink6 = Daniel Peterson | ||
Line 218: | Line 218: | ||
| last5 = Peterson | first5 = Daniel | authorlink5 = Daniel Peterson | | last5 = Peterson | first5 = Daniel | authorlink5 = Daniel Peterson | ||
| last6 = Connelly | first6 = Roger R | authorlink6 = | | last6 = Connelly | first6 = Roger R | authorlink6 = | ||
| last7 = Weil | first7 = R | | last7 = Weil | first7 = R | authorlink7 = | ||
| last8 = Robinson | first8 = SM | | last8 = Robinson | first8 = SM | authorlink8 = | ||
| last9 = Ablashi | first9 = Dharam V | authorlink9 = Dharam Ablashi | | last9 = Ablashi | first9 = Dharam V | authorlink9 = Dharam Ablashi | ||
| last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = | | last10 = Salahuddin | first10 = Sayeef Z | authorlink10 = | ||
| last11 = Pearson | first11 = GR | authorlink11 = | | last11 = Pearson | first11 = GR | authorlink11 = | ||
| last12 = Hoover | first12 = R | | last12 = Hoover | first12 = R | authorlink12 = | ||
| title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | | title = Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome | ||
| journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | | journal = Archives of Internal Medicine | volume = 152 | issue = 8 | page = 1611-1616 | ||
Line 268: | Line 268: | ||
</ref> | </ref> | ||
<ref name="Nagy-Szakal, 2018">{{Citation | <ref name="Nagy-Szakal, 2018">{{Citation | ||
| last1 = Nagy-Szakal | first1 = Dorottya | | last1 = Nagy-Szakal | first1 = Dorottya | authorlink1 = Dorottya Nagy-Szakal | ||
| last2 = Barupal | first2 = Dinesh K. | authorlink2 = | | last2 = Barupal | first2 = Dinesh K. | authorlink2 = | ||
| last3 = Lee | | last3 = Lee | first3 = Bohyun | authorlink3 = | ||
| last4 = Che | | last4 = Che | first4 = Xiaoyu | authorlink4 = | ||
| last5 = Williams | first5 = Brent L. | | last5 = Williams | first5 = Brent L. | authorlink5 = | ||
| last6 = Kahn | | last6 = Kahn | first6 = Ellie J. R. | authorlink6 = | ||
| last7 = Ukaigwe | first7 = Joy E. | | last7 = Ukaigwe | first7 = Joy E. | authorlink7 = | ||
| last8 = Bateman | first8 = Lucinda | | last8 = Bateman | first8 = Lucinda | authorlink8 = Lucinda Bateman | ||
| last9 = Klimas | first9 = Nancy G. | | last9 = Klimas | first9 = Nancy G. | authorlink9 = Nancy Klimas | ||
| last10 = Komaroff | first10 = Anthony L. | authorlink10 = Anthony Komaroff | | last10 = Komaroff | first10 = Anthony L. | authorlink10 = Anthony Komaroff | ||
| last11 = Levine | first11 = Susan | | last11 = Levine | first11 = Susan | authorlink11 = Susan Levine | ||
| last12 = Montoya | first12 = Jose G. | | last12 = Montoya | first12 = Jose G. | authorlink12 = Jose Montoya | ||
| last13 = Peterson | first13 = Daniel L. | authorlink13 = Daniel Peterson | | last13 = Peterson | first13 = Daniel L. | authorlink13 = Daniel Peterson | ||
| last14 = Levin | first14 = Bruce | | last14 = Levin | first14 = Bruce | authorlink14 = Bruce Levin | ||
| last15 = Hornig | first15 = Mady | | last15 = Hornig | first15 = Mady | authorlink15 = Mady Hornig | ||
| last16 = Fiehn | first16 = Oliver | | last16 = Fiehn | first16 = Oliver | authorlink16 = | ||
| last17 = Lipkin | first17 = W. Ian | | last17 = Lipkin | first17 = W. Ian | authorlink17 = Ian Lipkin | ||
| title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | | title = Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics | ||
| journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | | journal = Scientific Reports | volume = 8 | issue = 1 | page = 10056 | ||
Line 307: | Line 307: | ||
</ref> | </ref> | ||
<ref name="Strayer,1995">{{Citation | <ref name="Strayer,1995">{{Citation | ||
| last1 = Strayer | first1 = DR | | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | ||
| last2 = Carter | first2 = W | | last2 = Carter | first2 = W | authorlink2 = William Carter | ||
| last3 = Strauss | first3 = KI | | last3 = Strauss | first3 = KI | authorlink3 = Kenneth Strauss | ||
| last4 = Brodsky | first4 = I | | last4 = Brodsky | first4 = I | authorlink4 = | ||
| last5 = Suhadolnik | first5 = R | | last5 = Suhadolnik | first5 = R | authorlink5 =Robert Suhadolnik | ||
| last6 = Ablashi | first6 = D | | last6 = Ablashi | first6 = D | authorlink6 = Dharam Ablashi | ||
| last7 = Henry | first7 = B | | last7 = Henry | first7 = B | authorlink7 = | ||
| last8 = Mitchell | first8 = WM | | last8 = Mitchell | first8 = WM | authorlink8 = William Mitchell | ||
| last9 = Bastien | first9 = S | | last9 = Bastien | first9 = S | authorlink9 =Sheila Bastien | ||
| last10 = Peterson | first10 = D | | last10 = Peterson | first10 = D | authorlink10 = Daniel Peterson | ||
| title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | | title = Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen | ||
| journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | | journal = Journal of Chronic Fatigue Syndrome | volume = 1 | issue = 1 | page = 35-53 | ||
Line 324: | Line 324: | ||
</ref> | </ref> | ||
<ref name="Strayer, 2012">{{Citation | <ref name="Strayer, 2012">{{Citation | ||
| last1 = Strayer | first1 = DR | | last1 = Strayer | first1 = DR | authorlink1 = David Strayer | ||
| last2 = Carter | first2 = WA | | last2 = Carter | first2 = WA | authorlink2 = William Carter | ||
| last3 = Stouch | first3 = BC | | last3 = Stouch | first3 = BC | authorlink3 = | ||
| last4 = Stevens | first4 = SR | | last4 = Stevens | first4 = SR | authorlink4 = Staci Stevens | ||
| last5 = Bateman | first5 = L | | last5 = Bateman | first5 = L | authorlink5 = Lucinda Bateman | ||
| last6 = Cimoch | first6 = PJ | | last6 = Cimoch | first6 = PJ | authorlink6 = | ||
| last7 = Lapp | first7 = CW | | last7 = Lapp | first7 = CW | authorlink7 =Charles Lapp | ||
| last8 = Peterson | first8 = DL | | last8 = Peterson | first8 = DL | authorlink8 = Daniel Peterson | ||
| last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | | last9 = Chronic Fatigue Syndrome AMP-516 Study Group | authorlink9 = | ||
| last10 = Mitchell | first10 = WM | | last10 = Mitchell | first10 = WM | authorlink10 = William Mitchell | ||
| title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | | title = A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. | ||
| journal = PLoS One | volume = 7 | issue = 3 | page = e31334 | | journal = PLoS One | volume = 7 | issue = 3 | page = e31334 |
Revision as of 04:43, May 11, 2022
Daniel L. Peterson, MD, is a physician in Incline Village, Nevada specializing in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). He was at the epicenter of the 1984 Incline Village chronic fatigue syndrome outbreak[1] and continues to be a leader in treatment and research about ME/CFS, serving on Simmaron Research’s Scientific Advisory Board and the Faculty of Health Sciences and Medicine at Griffith University in Queensland, Australia.[2]
He helped establish the Whittemore Peterson Institute (WPI) which was renamed in 2016 the Nevada Center for Biomedical Research.[3] He left in 2010 to return to private practice at Sierra Internal Medicine, Incline Village, Nevada.[4] In 2019, he joined the scientific advisory board of the Open Medicine Foundation.[5]
Dr. Peterson was the first physician to use Ampligen, an immunomodulator made by AIM ImmunoTech (formerly Hemispherx Biopharma), in the treatment for ME/CFS, using it on Nancy Kaiser, a very severe patient.[6] He has participated in every Ampligen trial since, up to the AMP-511, open label, cost-recovery trial available today.[7]
Several documentaries about myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have featured Dr. Peterson, including, I Remember Me and Forgotten Plague, and the news feature, Sick and Tired.
Awards[edit | edit source]
- 2003, Rudy Perpich Senior Lectureship Award, presented to a distinguished CFS/FM scientist, physician or healthcare worker awarded by IACFS/ME[8]
- 2007, Nelson Gantz Outstanding Clinician Award awarded to a physician who emulates Nelson Gantz's clinical acumen, his passion for medicine, and his empathy for persons with CFS/FM awarded by IACFS/ME[8]
Writing committees[edit | edit source]
- 2003, Canadian Consensus Criteria - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[9] (Full Text)
- 2015, IOM Committee on Diagnostic Criteria for ME/CFS - Dr Peterson was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[10]
Notable studies[edit | edit source]
- 1992, A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection[11] (Abstract)
- 1992, Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome[12] (Abstract - can request full article)
- 1995, Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen[13] (Abstract)
- 1997, Editorial - Chronic Fatigue Syndrome and Disability[14] (Abstract)
- 2000, Chronic Fatigue Syndrome and Cancer[15] (Abstract)
- 2001, Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California: A Ten-Year Follow-Up of an Outbreak [16] (Abstract)
- 2003, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols[17] (Full Text)
- 2004, Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway[18] (Full Text)
- 2012, A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus[19] (Abstract)
- 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome[20] (Full Text)
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[21] (Full Text)
- 2015, Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[22] (Full Text)
- 2015, Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome[23] (Abstract)
- 2015, Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study[24] (Abstract)
- 2015, Distinct plasma immune signatures in ME/CFS are present early in the course of illness[25] - (Full text)
- 2016, Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome[26] (Abstract)
- 2017, Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[27] (Full Text)
- 2017, Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study[28] (Full Text)
- 2017, Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations[29] (Full Text)
- 2018, Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis[30] (Full text)
- 2018, Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics[31] (Full Text)
- 2020, Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations[32] - (Full text)
Talks and interviews[edit | edit source]
ME/CFS Alert[edit | edit source]
- 2012, Episode 26, ME/CFS Alert interview
- 2013, Episode 50, ME/CFS Alert interview
Invest in ME International ME Conference[edit | edit source]
- 2007, Speaker on Day 1 of the 2nd Invest in ME International ME Conference on Experiences of Research into ME/CFS: Past, Present, and Future - (Video)
- 2007, Speaker on Day 2 of the 2nd Invest in ME International ME Conference on Clinical Research - (Video)
- 2009, Speaker at the 4th Invest in ME International ME Conference on Treatment Regimes for the Most Severe Cases[33] DVD available
- 2012, Speaker at the 7th Invest in ME International ME Conference on Clinical Research Update 2012[34] DVD available
- 2013, Speaker at the 8th Invest in ME International ME Conference on Key Note Speech: The Mainstreaming of ME Research[35] DVD available
Other[edit | edit source]
- 1996, Primetime Live TV Show - Sick and Tired - Incline Village Outbreak[36]
- 2000 Documentary, I Remember Me, directed by Kim A. Snyder[37]
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 2
- 2011, Dr. med. Dan Peterson (Simmaron Research) - Diagnose und Behandlung von ME/CFS, Teil 1
- 2012, Phoenix Rising - Dr Daniel Peterson (July 12)
- 2015, 2015 De osynliga -Seminarium om ME/CFS, Sweden 19 October
- 2017, Solve ME/CFS Initiative’s 2nd Annual Discovery Forum: Presentation by Dr. Dan Peterson
Online presence[edit | edit source]
See also[edit | edit source]
- Ampligen
- Sierra Internal Medicine
- 1984 Incline Village chronic fatigue syndrome outbreak
- Paul Cheney
- List of myalgic encephalomyelitis and chronic fatigue syndrome outbreaks
- Canadian Consensus Criteria
Learn more[edit | edit source]
- Wikipedia - Daniel Peterson (physician)
- 1990, Chronic Fatigue Syndrome
- 2019, A Town for People with Chronic Fatigue Syndrome - New Yorker - about Ampligen
References[edit | edit source]
- ↑ "Dr. Dan Peterson (Sierra Internal Medicine, Incline Village, Nevada) - Health Rising". Health Rising. Retrieved August 13, 2018.
- ↑ "Collaborators - Simmaron Research". Simmaron Research. Retrieved August 13, 2018.
- ↑ "About Us". Nevada Center for Biomedical Research. Retrieved April 13, 2022.
- ↑ "History of Changes for Study: NCT00215813 | Study of Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. April 8, 2010. Retrieved April 13, 2020.
- ↑ "Daniel L. Peterson, MD". Open Medicine Foundation. Retrieved April 1, 2019.
- ↑ "TREATING THE DISEASE, NOT THE SYMPTOMS: NCF'S RESEARCH MOVES CFIDS/ME ONE STEP CLOSER TO NEOPLASTIC DISEASE PROCESS". www.ncf-net.org. Retrieved August 13, 2018.
- ↑ "Ampligen in Chronic Fatigue Syndrome". ClinicalTrials.gov. Retrieved August 13, 2018.
- ↑ 8.0 8.1 "IACFS/ME Awardees". IACFS/ME. Retrieved April 23, 2020.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
- ↑ Buchwald, Dedra; Cheney, Paul R.; Peterson, Daniel L.; Henry, Berch; Wormsley, Susan B.; Geiger, Ann; Ablashi, Dharam V.; Salahuddin, S. Zaki; Saxinger, Carl; Biddle, Royce; Kikinis, Ron; Jolesz, Ferenc A.; Folks, Thomas; Balachandran, N.; Peter, James B.; Gallo, Robert C.; Komaroff, Anthony L. (1992), "A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection", Annals of Internal Medicine, 116 (2): 103-113, PMID 1309285
- ↑ Levine, Paul H.; Jacobson, Steven; Pocinki, Alan G.; Cheney, Paul; Peterson, Daniel; Connelly, Roger R; Weil, R; Robinson, SM; Ablashi, Dharam V; Salahuddin, Sayeef Z; Pearson, GR; Hoover, R (1992), "Clinical, Epidemiologic, and Virologic Studies in Four Clusters of the Chronic Fatigue Syndrome", Archives of Internal Medicine, 152 (8): 1611-1616, doi:10.1001/archinte.1992.00400200049009
- ↑ Strayer, DR; Carter, W; Strauss, KI; Brodsky, I; Suhadolnik, R; Ablashi, D; Henry, B; Mitchell, WM; Bastien, S; Peterson, D (1995), "Long Term Improvements in Patients with Chronic Fatigue Syndrome Treated with Ampligen", Journal of Chronic Fatigue Syndrome, 1 (1): 35-53, doi:10.1300/J092v01n01_04
- ↑ Peterson, Daniel L. (January 1997). "Chronic Fatigue Syndrome and Disability". Journal of Chronic Fatigue Syndrome. 3 (4): 5–7. doi:10.1300/j092v03n04_02. ISSN 1057-3321.
- ↑ Levine, Paul H.; Pilkington, Deborah; Strickland, Paula; Peterson, Daniel (2000), "Chronic Fatigue Syndrome and Cancer", Journal of Chronic Fatigue Syndrome, 7 (1): 29-38, doi:10.1300/J092v07n01_04
- ↑ Strickland, Paula S.; Levine, Paul H.; Peterson, Daniel L.; O'Brien, Karen; Fears, Thomas (January 2001). "Neuromyasthenia and Chronic Fatigue Syndrome (CFS) in Northern Nevada/California". Journal of Chronic Fatigue Syndrome. 9 (3–4): 3–14. doi:10.1300/j092v09n03_02. ISSN 1057-3321.
- ↑ Carruthers, Bruce M.; Jain, Anil Kumar; De Meirleir, Kenny L.; Peterson, Daniel L.; Klimas, Nancy G.; Lerner, A. Martin; Bested, Alison C.; Flor-Henry, Pierre; Joshi, Pradip; Powles, A C Peter; Sherkey, Jeffrey; van de Sande, Marjorie (January 2003). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Journal of Chronic Fatigue Syndrome. 11 (1): 7–115. doi:10.1300/j092v11n01_02. ISSN 1057-3321.
- ↑ Suhadolnik, Robert J.; Peterson, Daniel L.; Reichenbach, Nancy L.; Roen, Gail; Metzger, Melodie; McCahan, John; O'brien, Karen; Welsch, Suzanne; Gabriel, Jerome; Gaughan, John P.; McGregor, Neil R. (2004). "Clinical and Biochemical Characteristics Differentiating Chronic Fatigue Syndrome from Major Depression and Healthy Control Populations: Relation to Dysfunction in the RNase L Pathway". Journal of Chronic Fatigue Syndrome. 12 (1): 5–35. doi:10.1300/J092v12n01_02.
- ↑ Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12
- ↑ Strayer, DR; Carter, WA; Stouch, BC; Stevens, SR; Bateman, L; Cimoch, PJ; Lapp, CW; Peterson, DL; Chronic Fatigue Syndrome AMP-516 Study Group; Mitchell, WM (2012), "A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.", PLoS One, 7 (3): e31334, doi:10.1371/journal.pone.0031334, PMID 22431963
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Peterson, D; Brenu, EW; Gottschalk, G; Ramos, SB; Nguyen, T; Staines, D; Marshall-Gradisnik, S (2015), "Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis", Mediators of Inflammation, 2015, doi:10.1155/2015/929720
- ↑ Klimas, N.G.; Ironson, G.; Carter, A.; Balbin, E.; Bateman, L.; Felsenstein, D.; Levine, S.; Peterson, D.; Chiu, K.; Allen, A.; Cunningham, K.; Gottschalk, C.G.; Fletcher, M; Hornig, M.; Canning, C.; Komaroff, A.L. (2015), "Findings from a clinical and laboratory database developed for discovery of pathogenic mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome", Fatigue: Biomedicine, Health & Behavior, 3 (2): 75-96, doi:10.1080/21641846.2015.1023652
- ↑ Bateman, L.; Darakjy, S.; Klimas, N.; Peterson, D.; Levine, S.M.; Allen, A.; Carlson, S.A.; Balbin, E.G.; Gottschalk, G.; March, D. (2015), "Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study", Fatigue: Biomedicine, Health & Behavior, 3 (1): 1-15, doi:10.1080/21641846.2014.978109
- ↑ Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015). "Distinct plasma immune signatures in ME/CFS are present early in the course of illness". Science Advances. 1 (1). doi:10.1126/sciadv.1400121.
- ↑ Hornig, M; Gottschalk, G; Peterson, D; Knox, KK; Schultz, AF; Eddy, ML; Che, X; Lipkin, WI (2016), "Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome.", Molecular Psychiatry, 21 (2): 261-9, doi:10.1038/mp.2015.29
- ↑ Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y
- ↑ Unger, Elizabeth R.; Lin, Jin-Mann S.; Tian, Hao; Natelson, Benjamin H; Lange, Gudrun; Vu, Diana; Blate, Michelle; Klimas, Nancy G.; Balbin, Elizabeth G.; Bateman, Lucinda; Allen, Ali; Lapp, Charles W.; Springs, Wendy; Kogelnik, Andreas M.; Phan, Catrina C.; Danver, Joan; Podell, Richard N.; Fitzpatrick, Trisha; Peterson, Daniel L.; Gottschalk, C. Gunnar; Rajeevan, Mangalathu S.; MCAM Study Group (2017), "Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study.", American Journal of Epidemiology, 1–10, doi:10.1093/aje/kwx029
- ↑ Hornig, M; Gottschalk, G; Eddy, ML; Che, X; Ukaigwe, JE; Peterson, DL; Lipkin, WI (2017), "Immune network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome with atypical and classical presentations", Translational Psychiatry, 7 (4), doi:10.1038/tp.2017.44
- ↑ Marshall-Gradisnik, Sonya; Fretel, Marshall; Eaton, Natalie; Cabanas, Helene; Balinas, Cassandra; Gopalan, Vinod; Petersen, Daniel; Passmore, Rachel; Tang, Kevin; Haque, Mazhar; Lam, Alfred; Staines, Donald (May 31, 2018). "Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis". International Journal of Clinical Medicine. 09 (05): 467. doi:10.4236/ijcm.2018.95040.
- ↑ Nagy-Szakal, Dorottya; Barupal, Dinesh K.; Lee, Bohyun; Che, Xiaoyu; Williams, Brent L.; Kahn, Ellie J. R.; Ukaigwe, Joy E.; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Levin, Bruce; Hornig, Mady; Fiehn, Oliver; Lipkin, W. Ian (2018), "Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics", Scientific Reports, 8 (1): 10056, doi:10.1038/s41598-018-28477-9
- ↑ Mandarano, Alexandra H.; Maya, Jessica; Giloteaux, Ludovic; Peterson, Daniel L.; Maynard, Marco; Gottschalk, C. Gunnar; Hanson, Maureen R.; Maureen Hanson (February 10, 2020). "Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations". Journal of Clinical Investigation. 130 (3): 1491–1505. doi:10.1172/jci132185.
- ↑ "Invest in ME Research - IIMEC4". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC7 International ME Conference 2012". Invest in ME Research. Retrieved February 4, 2020.
- ↑ "Invest in ME Research - IIMEC8 International ME Conference 2013". Invest in ME Research. Retrieved February 4, 2020.
- ↑ CFS and the CDC's Failure to Respond: Primetime Live (1996), retrieved February 4, 2020
- ↑ I Remember Me, retrieved February 4, 2020